help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulich, T. R.
Right arrow Articles by Eisenberg, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulich, T. R.
Right arrow Articles by Eisenberg, S. P.

American Journal of Pathology, Vol 141, 61-68, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation

TR Ulich, K Guo, S Yin, J del Castillo, ES Yi, RC Thompson and SP Eisenberg
Department of Pathology, University of California, San Diego School of Medicine 92103.

After the intravenous (IV) injection of endotoxin, (lipopolysaccharide [LPS]), in the rat, interleukin-1 alpha/beta (IL-1 alpha/beta) mRNA expression peaks at 1 hour in whole organ RNA preparations of the lung, liver, spleen, and bowel. Interleukin-1 receptor antagonist (IL-1ra) mRNA peaks at 2 to 4 hours, consistent with the hypothesis that IL-1ra acts as an endogenous negative feedback mechanism to downregulate the proinflammatory effects of IL-1. After the intratracheal (IT) injection of LPS, however, IL-1 and IL-1ra mRNA levels in whole lung peak at 6 hours, concurrent with the maximum influx of neutrophils (PMNs) into the bronchoalveolar space. To address the cellular source of IL-1 and IL-1ra mRNA in the lung during acute pneumonitis, mRNA levels were studied in bronchoalveolar lavage (BAL) macrophages incubated with LPS in vitro for 6 hours as compared with BAL cells (95% PMNs) obtained 6 hours after IT injection of LPS. A much greater expression of IL-1 and IL-1ra mRNA was observed in PMN-rich BAL cells obtained after IT injection of LPS, suggesting that PMNs contribute substantially to IL-1 and IL-1ra mRNA expression. Fractionation of alveolar macrophage- enriched and PMN-enriched subpopulations from the BAL cells obtained at 6 hours after IT injection of LPS confirmed that neutrophils are a source of IL-1 and IL-1ra mRNA. The difference in the kinetics of IL-1 and IL-1ra mRNA expression in whole lung RNA preparations after IV and IT injections of LPS is due to the contribution of PMNs that appear in the lung in large numbers after IT injection. Finally, human peripheral blood PMNs were found to express IL-1ra mRNA and protein after in vitro incubation with LPS. PMNs may contribute to the up- and downregulation of their own accumulation by expressing both IL-1 and IL-1ra.


This article has been cited by other articles:


Home page
Innate ImmunityHome page
J.-M. Cavaillon and D. Annane
Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS
Innate Immunity, June 1, 2006; 12(3): 151 - 170.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Spight, B. Zhao, M. Haas, S. Wert, A. Denenberg, and T. P. Shanley
Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo
Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L251 - L265.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Ueno, T. Matsuda, S. Hashimoto, F. Amaya, Y. Kitamura, M. Tanaka, A. Kobayashi, I. Maruyama, S. Yamada, N. Hasegawa, et al.
Contributions of High Mobility Group Box Protein in Experimental and Clinical Acute Lung Injury
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1310 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. P. JUFFERMANS, A. VERBON, J. T. BELISLE, P. J. HILL, P. SPEELMAN, S. J. H. van DEVENTER, and T. van der POLL
Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung . A Role for Interleukin-1
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 486 - 489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. BECKER, W. A. CLAPP, J. QUAY, K. L. FREES, H. S. KOREN, and D. A. SCHWARTZ
Compartmentalization of the Inflammatory Response to Inhaled Grain Dust
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1309 - 1318.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
C. M. Pastor and P. M. Suter
Hepatic Hemodynamics and Cell Functions in Human and Experimental Sepsis
Anesth. Analg., August 1, 1999; 89(2): 344 - 344.
[Full Text] [PDF]


Home page
J. Immunol.Home page
M. Radulovic, F. M. Dautzenberg, S. Sydow, J. Radulovic, and J. Spiess
Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells
J. Immunol., March 1, 1999; 162(5): 3013 - 3021.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. K. Held, X. Weihua, L. Yuan, D. V. Kalvakolanu, and A. S. Cross
Gamma Interferon Augments Macrophage Activation by Lipopolysaccharide by Two Distinct Mechanisms, at the Signal Transduction Level and via an Autocrine Mechanism Involving Tumor Necrosis Factor Alpha and Interleukin-1
Infect. Immun., January 1, 1999; 67(1): 206 - 212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. J. Schultz, A. W. Rijneveld, S. Florquin, C. K. Edwards, C. A. Dinarello, and T. van der Poll
Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia
Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L285 - L290.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.